Brian K. Kobilka

Brian K. Kobilka is a renowned American biochemist and molecular biologist who has made significant contributions to the field of G protein-coupled receptors (GPCRs). His work has been influenced by notable scientists such as Robert Lefkowitz, Alfred G. Gilman, and Martin Rodbell. Kobilka's research has been supported by institutions like the National Institutes of Health (NIH) and the Howard Hughes Medical Institute (HHMI). He has also collaborated with researchers from Stanford University, Duke University, and the University of California, San Francisco.

● Early Life and Education

Kobilka was born in Little Falls, Minnesota, and grew up in a family of Catholic farmers. He developed an interest in science and mathematics at an early age, which was encouraged by his parents and teachers at Little Falls High School. Kobilka pursued his undergraduate degree in biology and chemistry at the University of Minnesota Duluth, where he was influenced by professors such as Franklyn G. Prendergast and Earl R. Stadman. He then moved to Yale University to earn his Ph.D. in biochemistry, working under the guidance of Jesuit biochemist Patrick J. Casey and Robert J. Lefkowitz.

● Career

Kobilka began his career as a postdoctoral researcher at Duke University, working in the laboratory of Robert Lefkowitz. During this period, he collaborated with researchers from Stanford University, Harvard University, and the University of California, Los Angeles (UCLA). In 1989, Kobilka joined the faculty at Stanford University School of Medicine, where he established his own laboratory and began to investigate the structure and function of G protein-coupled receptors (GPCRs). He has also held appointments at the Howard Hughes Medical Institute (HHMI) and the National Institutes of Health (NIH), and has worked with scientists from MIT, Caltech, and the University of Cambridge.

● Research and Discoveries

Kobilka's research has focused on the structure and function of G protein-coupled receptors (GPCRs), which are a large family of cell surface receptors that play critical roles in cell signaling and human disease. His laboratory has used a combination of biochemical, biophysical, and structural biology techniques to study the structure and dynamics of GPCRs, including X-ray crystallography and NMR spectroscopy. Kobilka's work has been influenced by collaborations with researchers such as Raymond C. Stevens, Vadim Cherezov, and Michael A. Hanson, and has involved institutions like the Scripps Research Institute, University of Southern California, and the European Molecular Biology Laboratory (EMBL). His discoveries have shed light on the mechanisms of G protein-coupled receptor activation and regulation, and have implications for the development of new therapeutics for human diseases such as cancer, diabetes, and neurological disorders.

● Awards and Honors

Kobilka has received numerous awards and honors for his contributions to the field of biochemistry and molecular biology, including the Nobel Prize in Chemistry in 2012, which he shared with Robert Lefkowitz. He has also been recognized with awards from the National Academy of Sciences, the American Academy of Arts and Sciences, and the Royal Society. Kobilka has received honors from institutions such as Harvard University, Stanford University, and the University of California, Berkeley, and has been elected as a member of the National Academy of Medicine and the German Academy of Sciences Leopoldina.

● Personal Life

Kobilka is married to Tong Sun Kobilka, a biochemist who has worked at Stanford University and the University of California, San Francisco. He has two children, Jason Kobilka and Emily Kobilka, who have pursued careers in science and medicine. Kobilka is a Catholic and has stated that his faith has influenced his approach to science and his commitment to social justice. He has also been involved in philanthropic efforts, including support for the St. Jude Children's Research Hospital and the American Cancer Society. Kobilka has served on the boards of organizations such as the Burroughs Wellcome Fund and the Jane Coffin Childs Memorial Fund for Medical Research, and has worked with scientists from Oxford University, University of Toronto, and the Pasteur Institute.